This test is most useful if any of these apply to you.
If you have ever wondered how much time your ovaries actually have left, this is the test that gives you a direct look. A trained sonographer counts the small fluid-filled follicles in both of your ovaries, and that number tells you, in real time, roughly how many eggs are currently in the recruitable pool.
Unlike a hormone level pulled from a tube of blood, this is an image of your ovaries themselves. The number it produces is one of the most concrete measures of ovarian reserve available to you, and it can change how you think about fertility timing, IVF planning, and conditions like PCOS or endometriosis.
AFC (antral follicle count) is the total number of small follicles, typically between 2 and 10 millimeters across, visible in both ovaries on a transvaginal ultrasound. These are the follicles that have already left the resting pool and are competing for the chance to release an egg in an upcoming cycle. They are also the follicles that respond to fertility drugs.
The count is best done with a high-frequency vaginal probe and a systematic sweep of each ovary in two planes. Newer 3D techniques and even at-home virtual scans (guided remotely by a trained technologist) produce counts that are equivalent to standard in-clinic 2D scans, with image quality and patient satisfaction shown to be non-inferior in a randomized study of 56 women.
AFC was once thought to require testing on cycle days 2 to 5, but newer evidence shows that a count taken on any day of your menstrual cycle gives similar predictive value for ovarian response, oocyte yield, and correlation with AMH (anti-Mullerian hormone, a blood hormone reflecting the same follicle pool). This makes the test far more practical than it used to be.
AFC is among the strongest single predictors of how your ovaries will respond to stimulation in IVF. In a meta-analysis pooling results across studies, AFC outperformed basal FSH (follicle-stimulating hormone, the pituitary signal that drives follicle growth) for predicting poor ovarian response, with sensitivities and specificities near 90% at common thresholds.
In a large study of 9,484 women classified under the POSEIDON framework for low-prognosis patients, AFC and AMH together stratified women into categories that genuinely change treatment decisions. In another analysis of 89,002 IVF patients, AFC combined with age sharpened the prediction of poor response well beyond age alone.
One important caveat: AFC predicts how many eggs you can recruit, not whether you will get pregnant. Egg quality and embryo health depend more strongly on age than on follicle count. The number tells you about the size of the pool, not the health of any individual egg.
In a prospective study of 89 premenopausal women that compared imaging to actual ovarian tissue, AFC was associated with the size of the primordial follicle pool, the deep reserve of eggs you were born with. This supports AFC as a real biological marker, not just a procedural count.
The follicles being counted contain granulosa cells (the support cells around each egg) that produce AMH, a hormone you can also measure in blood. AFC and AMH are tightly correlated and capture overlapping information. When they disagree, AFC has been shown in a study of 1,121 IVF patients to be the more reliable predictor of actual ovarian response.
A low AFC indicates diminished ovarian reserve, which has real consequences. In a meta-analysis of recurrent pregnancy loss, low AMH and low AFC were both associated with higher odds of miscarriage. A single-center study of 773 women undergoing IVF found that diminished ovarian reserve was linked to higher rates of chromosomally abnormal embryos, which helps explain why declining reserve translates into harder cycles even when eggs are retrieved.
Endometriosis lowers AFC. A meta-analysis of women with endometriosis confirmed reduced antral follicle count, lower AMH, and higher FSH compared with controls, with the effect strongest in advanced disease and in ovaries directly affected by endometriomas.
Cancer survivors who received chemotherapy show lower AFC and AMH than women without that history. In a study of 3,904 childhood cancer survivors, cyclophosphamide, procarbazine, and abdominal or pelvic radiotherapy were each independently associated with abnormal ovarian reserve markers, with dose-response relationships for procarbazine and radiation.
A high AFC has different meaning entirely. Polycystic ovarian morphology, one of the diagnostic features of polycystic ovary syndrome, is defined by an excess of small antral follicles. The Androgen Excess and PCOS Society task force has proposed a follicle number per ovary of at least 25 (using modern high-frequency probes) as a research threshold for polycystic ovarian morphology in adult women.
In women with PCOS undergoing IVF, a high AFC is also one of the strongest predictors of ovarian hyperstimulation syndrome, a serious complication of fertility treatment. A study of 2,699 women with PCOS undergoing IVF identified AFC as a major predictor of OHSS severity, which directly changes how stimulation protocols should be designed.
It can feel confusing that both high and low AFC signal problems. The key is to understand that AFC is not a good-number versus bad-number test. It is a phenotype indicator. A low count tells you the recruitable pool is small, which matters most if you want to have children. A high count tells you the pool is unusually large, which often reflects an underlying ovulatory disorder. Different patterns carry different risks, and the same number means different things in different bodies.
AFC depends on who is doing the counting and how. A study of 203 women showed that intra-observer and inter-observer reproducibility are generally high, but agreement declines when follicle counts are very high. Operator skill and probe frequency matter.
AFC is more useful as a trend than as a single number. Because counts vary between cycles and observers, a single reading can mislead. A baseline measurement, a repeat in 6 to 12 months, and then annual tracking gives you a real trajectory you can act on. If you are actively trying to preserve fertility or undergoing treatment that affects the ovaries, retesting every 3 to 6 months can make sense.
An age-related nomogram built from 3,821 women shows that AFC peaks in the early twenties and declines with age. Knowing where your number falls relative to others your age, and how it changes over time, is more informative than any one isolated count.
If your AFC is lower than expected for your age, pair it with an AMH blood test, FSH, and estradiol drawn early in your cycle. The combination paints a clearer picture than any single marker. Consider seeing a reproductive endocrinologist, especially if you are planning to delay pregnancy or have a family history of early menopause.
If your AFC is high, ask whether you also have signs of PCOS (irregular cycles, hyperandrogenism, or insulin resistance). In that case, fasting glucose, fasting insulin, HbA1c (a marker of average blood sugar over three months), and androgens like total testosterone and DHEA-S round out the workup. A high count in someone planning IVF requires careful protocol selection to avoid hyperstimulation.
If AFC and AMH disagree, AFC is generally the more reliable predictor of how your ovaries will actually behave during stimulation, based on data from 1,121 IVF patients. The discordance itself is worth investigating, and a fertility specialist can help interpret it.
Evidence-backed interventions that affect your AFC level
Antral Follicle Count is best interpreted alongside these tests.